Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PEP005 Topical Gel for Superficial Basal Cell Carcinoma on the Trunk
NCT00432185Phase 2Completed
- Sponsor
- Peplin
- Start
- Feb 2007
- Primary completion
- Mar 2010
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ingenol mebutate in basal cell carcinoma (BCC), sponsored by Peplin. Started Feb 2007; status: completed.
02
Drugs
ingenol mebutate
03
Conditions
basal cell carcinoma (BCC)
Beyond the preview
Go deeper on NCT00432185.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00432185.